AI Multitask Model for HCC Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

7000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We will integrate multi-modal cardiac data via an AI multitask framework to develop and validate concurrent models for liver function, treatment prognosis, and microvascular invasion (MVI) prediction in hepatocellular carcinoma. The resulting tool will be prospectively deployed to guide personalized surgical, TACE, and systemic therapy decisions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Assessment for HBV-Related Liver Cancer

NCT07160946

HBV-related Liver Cirrhosis

RECRUITING

Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data

NCT06849180

Combined Hepatocellular-cholangiocarcinoma Combined Hepatocellular Carcinoma and Cholangiocarcinoma Combined Hepatocellular and Cholangiocarcinoma

RECRUITING

Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria

NCT01570075

Hepatocellular Carcinoma

UNKNOWN PHASE4

TACE-HAIC vs. HAIC for Potentially Resectable HCC

NCT03591705

Potentially Resection Hepatocellular Carcinoma

UNKNOWN NA

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

NCT07042841

Liver Cancer, Adult

ENROLLING_BY_INVITATION

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatocellular Carcinoma (HCC)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comprehensive treatment

Comprehensive HCC therapies include liver resection, TACE, HAIC, targeted therapy, immunotherapy and radiotherapy

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age 18-75 years;
2. HCC diagnosed according to the European Association for the Study of the Liver/American Association for the Study of Liver Diseases criteria)
3. Eastern Cooperative Oncology Group performance status \< 2;
4. Child-Pugh class A or B liver function;